GME Meeting Planner
This satellite symposium will present the current standard of knowledge with respect to the diagnostics and evidence-based treatment options.
Satellite webcast symposium on the occasion of the 33rd ECNP Congress with educational financial support provided by Takeda / Global Medical Education.
This live virtual webcast is open to all attendees of the 33rd ECNP Congress. This session offers 2 CME credits. Online registration is not available, ECNP attendees are welcome to join us online. For more information or to register for the ECNP, please viist their website at: https://www.ecnp.eu/Congress2020/ECNPcongress
Attention Deficit Hyperactivity Disorder (ADHD) is a neurodevelopmental disorder of multifactorial pathogenesis. Traditionally, ADHD was assumed to be a childhood disorder. In the meantime, a persistence of symptoms into adulthood has been shown in 60% of those affected. Besides the core symptoms of inattention, hyperactivity and impulsivity, adults with ADHD often suffer from emotional dysregulation, comorbid disorders and functional impairment in multiple domains.
Standardized questionnaires for the assessment have been developed and effective psychopharmacological treatments are available. According to the recent evidence of efficacy and tolerability, stimulants, particularly amphetamines are the first-choice medication in adult with ADHD. Psychosocial treatments have also been studied.
The aim of our symposium is to present the current standard of knowledge with respect to the diagnostics and evidence-based treatment options. Relevant differential diagnoses and comorbid illnesses of adult ADHD are discussed and treatment recommendations also in complex cases are presented.
Are we missing the diagnosis of adult ADHD?
Adult ADHD is a prevalent disorder with a prevalence rate of at least 2.8% in the general population and highly comorbid with anxiety, mood, substance use, and personality disorders. Moreover, treatment of adults with ADHD is low in different countries. These results show that adult ADHD is still under-recognized and under-treated. In the talk potential underlying factors for underdiagnosing adult ADHD are discussed and helpful hallmarks for identifying ADHD in psychiatric patients with high risk for ADHD are presented.
Comorbid Illnesses in Adult ADHD
It is well known that in ADHD comorbidity is the rule rather than the exception and that a successful management of comorbidities is a main predictor of the longer-term outcome. Therefore evidence-based knowledge of comorbidities is crucial in the multimodal treatment of ADHD not only in children and adolescents but in particular in adulthood. In the symposium we will discuss the scientific background on optimized pharmacological and non-pharmacological treatment strategies under several comorbid conditions such as affective disorders, substance use disorders, Tic/Tourette syndrome and symptoms of autism spectrum disorders.
Managing Adult ADHD by the Evidence
ADHD in adults usually presents as an across the lifespan impairing condition. The stigma surrounding ADHD in adults, mainly due to lack of knowledge, increases the suffering of patients. Education on the evidence-based treatments of ADHD in adults must increase for mental health professionals. Nowadays, there are several diagnostic instruments and screening scales available in Adult ADHD. These can help to improve the diagnosis of ADHD in adults and the treatment. The evidence-based treatments for ADHD in adulthood will be reviewed and the different European guidelines and consensus will be presented. The talk will cover psychopharmacological and psychological treatments for Adult ADHD.
15:50 - 15:55: Opening Remarks
15:55 - 16:15: Are We Missing the Diagnosis of Adult ADHD – Alexandra Philipsen, MD ( University of Bonn)
16:15 - 16:35: Comorbid Illnesses in Adult ADHD – Michael Huss, MD ( University Medical Center Mainz)
16:35 - 16:55: Managing Adult ADHD by the Evidence – Antonio Ramos-Quiroga, MD (Vall d'Hebron University Hospital)
16:55 - 17:15: Q&A
17:15 - 17:20: Closing Remarks
Faculty Members Scheduled to Attend
Location and Date
GME is not taking registrations for this meeting. Please visit the ECNP's website for more information or to register: https://www.ecnp.eu/Congress2020/ECNPcongress